Literature DB >> 19020746

Adenovirus vectors with chimeric type 5 and 35 fiber proteins exhibit enhanced transfection of human pancreatic cancer cells.

Eiji Toyoda1, Ryuichiro Doi, Kazuhiro Kami, Tomohiko Mori, Daisuke Ito, Masayuki Koizumi, Atsushi Kida, Kazuyuki Nagai, Tatsuo Ito, Toshihiko Masui, Michihiko Wada, Masatoshi Tagawa, Shinji Uemoto.   

Abstract

Adenovirus (Ad) vectors are widely used for gene transfer. Efficient gene transfer into malignant cells is an important requirement for anticancer gene therapy, but transgene expression after transfer with adenoviral vectors varies among different cancer cell lines. Recently, Ad vectors containing chimeric type 5 and 35 fiber proteins have been developed. We evaluated the expression of coxsackie and adenovirus receptor (CAR), as well as integrins alphaV, beta3 and beta5, in seven human pancreatic cancer cell lines and assessed the relationship between expression of these molecules and Ad transfection efficiency. We compared the transfection efficiency of a conventional type 5 Ad vector (Ad5GFP) with that of an Ad vector containing chimeric type 5 and 35 fiber proteins (Ad5/35GFP), which expressed green fluorescent protein (GFP) driven by the cytomegalovirus promoter. There was strong CAR expression by AsPC-1, CFPAC-1 and PANC-1 cells, whereas the other cell lines showed weak expression. There was strong integrin beta3 expression by MIAPaCa-2, PANC-1 and Suit-2 cells, but expression by AsPC-1, BxPC-3, CFPAC-1 and HPAC cells was weak. Transfection efficiency of the vectors for human pancreatic cancer cell lines was not directly related to the CAR or integrin expression. However, transfection by Ad5/35GFP was significantly greater than by Ad5GFP at MOIs of 10 and 25 in all five human pancreatic cell lines. In conclusion, the Ad5/35GFP vector mediates more efficient gene transfer to human pancreatic cancer cells. These results may have implications for improving the efficiency of Ad-mediated gene transfer and developing adenoviral vectors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19020746

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  8 in total

1.  Improving gene transfer in human renal carcinoma cells: Utilization of adenovirus vectors containing chimeric type 5 and type 35 fiber proteins.

Authors:  Bishnu Acharya; Shuji Terao; Toru Suzuki; Michio Naoe; Katsuyuki Hamada; Hiroyuki Mizuguchi; Akinobu Gotoh
Journal:  Exp Ther Med       Date:  2010-05-01       Impact factor: 2.447

2.  Increased antitumor capability of fiber-modified adenoviral vector armed with TRAIL against bladder cancers.

Authors:  Youguang Zhao; Ying Li; Qingtang Wang; Liang Wang; Hang Yang; Mingli Li
Journal:  Mol Cell Biochem       Date:  2011-03-25       Impact factor: 3.396

3.  Cell entry and trafficking of human adenovirus bound to blood factor X is determined by the fiber serotype and not hexon:heparan sulfate interaction.

Authors:  Stéphanie Corjon; Gaëlle Gonzalez; Petra Henning; Alexei Grichine; Leif Lindholm; Pierre Boulanger; Pascal Fender; Saw-See Hong
Journal:  PLoS One       Date:  2011-05-26       Impact factor: 3.240

4.  HIF-1α effects on angiogenic potential in human small cell lung carcinoma.

Authors:  Jun Wan; Huiping Chai; Zaicheng Yu; Wei Ge; Ningning Kang; Wanli Xia; Yun Che
Journal:  J Exp Clin Cancer Res       Date:  2011-08-15

5.  Tropism-modification strategies for targeted gene delivery using adenoviral vectors.

Authors:  Lynda Coughlan; Raul Alba; Alan L Parker; Angela C Bradshaw; Iain A McNeish; Stuart A Nicklin; Andrew H Baker
Journal:  Viruses       Date:  2010-10-13       Impact factor: 5.818

6.  Adenoviruses using the cancer marker EphA2 as a receptor in vitro and in vivo by genetic ligand insertion into different capsid scaffolds.

Authors:  Michael Behr; Johanna K Kaufmann; Patrick Ketzer; Sarah Engelhardt; Martin Mück-Häusl; Pamela M Okun; Gabriele Petersen; Frank Neipel; Jessica C Hassel; Anja Ehrhardt; Alexander H Enk; Dirk M Nettelbeck
Journal:  PLoS One       Date:  2014-04-23       Impact factor: 3.240

7.  Superior infectivity of the fiber chimeric oncolytic adenoviruses Ad5/35 and Ad5/3 over Ad5-delta-24-RGD in primary glioma cultures.

Authors:  Aleksei A Stepanenko; Anastasiia O Sosnovtseva; Marat P Valikhov; Anastasia A Chernysheva; Sergey A Cherepanov; Gaukhar M Yusubalieva; Zsolt Ruzsics; Anastasiia V Lipatova; Vladimir P Chekhonin
Journal:  Mol Ther Oncolytics       Date:  2021-12-21       Impact factor: 7.200

8.  Pancreatic cancer gene therapy: from molecular targets to delivery systems.

Authors:  Cristina Fillat; Anabel Jose; Xavier Bofill-Deros; Ana Mato-Berciano; Maria Victoria Maliandi; Luciano Sobrevals
Journal:  Cancers (Basel)       Date:  2011-01-18       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.